Tip: Search for English results only. You can specify your search language in Preferences
... immunopotentiator, monophosphoryl lipid A, for a Men B antigen, which is coadsorbed to the same particle Formulation PLG/Men B PLG/Men B þMPL PLG/MPL/Men B ELISA titer 11,367 18,074 66,493 Bactericidal titer 512 2,048 8,192 The potency ...
... 免疫賦活剤として登場した cianidanole , levaminole , transfer factor などについて論じたいと考えたが、上記した各種治療剤あるいは治療方法からみて治療効果が認められないとか、死亡例などの報告がありわが国では市販中止されているため割愛させて載 ...
... Immunopotentiator can activate the immune system, improve the specific and nonspecific immunity of aquatic animals, thereby enhancing the ability to resist infection by pathogenic microorganisms. In recent years, aquaculture diseases ...
... immunopotentiator may pre- clude the need for a secondary immunization, hence reducing the amount of antigen needed. Moreover, some types of immunopotentiator may enable mucosal, needle-free delivery of the vaccine, or overcome non ...
... immunopotentiator should not induce a hypersensitivity reaction to host tissue nor to the immunopotentiator 312 313 5.3.1 Adjuvant arthritis 313 5.3.2 Induction of allergic responses to the injected antigen or to a competing antigen ...
... immunopotentiator Antimicrobial, immunopotentiator Lysozyme 0.0004 0.0004 14,000 Osteopontin 0.02 29,000 Antimicrobial, immunopotentiator Serum albumin 1.3 0.3 Many of the highly expressed proteins are proposed to have. 66,300 Bioactive ...
... (免疫抑制剤* )と逆に機能を亢進させる薬剤(免疫賦活剤)をいう、アレルギー疾患,自己免疫疾患、臓器移植における拒絶反応などの免疫反応を抑制または修飾するような薬物をいう。1 つは特異的免疫療法として使われるもので、種々のワクチン*が免疫の獲得 ...
... 免疫賦活薬が登場し,この非特異的免疫療法により癌患者の生存期間の延長が報ぜられている.しかしこれら免疫賦活薬の抗腫瘍性作用は必ずしも十分ではなく tumor burden を出来る限り減少し,免疫賦活薬と抗癌薬とを併用した免疫化学療法 immunochemotherapy ...
... immunopotentiator (TMC/OVA/ immunopotentiator nanoparticles) has been described.132 Many immunopotentiators were tested, including TLR ligands (LPS, PAM(3)CSK(4) (PAM), CpG DNA, the NOD- like receptor 2 ligand muramyl dipeptide (MDP) ...
... immunopotentiator bleomycin might have a synergistic effect in cancer immunotherapy . That is to say , when some immunopotentiator such as BCG is given the toxicity and growth of tumor cells as antigen might be weakened by bleomycin ...